New year, new Future Microbiology: welcome to Volume 18

References

• 1. Buonsenso D, Pujol FE, Munblit D, Pata D, McFarland S, Simpson FK. Clinical characteristics, activity levels and mental health problems in children with long coronavirus disease: a survey of 510 children. Future Microbiol. 17(8), 577–588 (2022).
  CASGoogle Scholar
• 2. Buonsenso D, Di Gennaro L, De Rose C et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long COVID. Future Microbiol. 17(7), 551–571 (2022).
  CASGoogle Scholar
• 3. Leptihn S, Loh B. Complexity challenges and costs of implementing phage therapy. Future Microbiol. 17(9), 643–646 (2022).
  CASGoogle Scholar
• 4. Paukner S, Moran GJ, Sandrock C et al. A plain language summary of how lefamulin alone can be used to treat pneumonia caught outside of the hospital due to common bacterial causes, including drug-resistant bacteria. Future Microbiol. 17(6), 397–410 (2022).
  CASGoogle Scholar
• 5. Frank M. Bucillamine in the treatment of patients with mild to moderate COVID-19: an interview with Michael Frank. Future Microbiol. 17(3), 157–159 (2022).
  CASGoogle Scholar
• 6. Future Microbiology. Twitter. https://twitter.com/fsgfmb
  Google Scholar
• 7. Linkedin group. Future Science Group Microbiology. http://www.linkedin.com/groups/8506116
  Google Scholar
• 8. Future Medicine. Future Microbiology. http://www.futuremedicine.com/loi/fmb
  Google Scholar